Sanofi’s Post

Join us for the second webinar in The Oral-Systemic Connection Series! Date: September 6th Time: 11am-12pm ET Register Here: https://bit.ly/3SPn0D8 This CME/CE-accredited session, titled "Oral Impact of Immunosuppression and Auto-Immune Disorders," will cover: • Oral Effects: Review oral effects of auto-immune disorders such as Sjogren’s Syndrome and cancers as well as side-effects from cancer treatments and other systemic therapies (BRONJ, etc) • Treatment Modalities: Discuss treatment modalities and options on both the oral and systemic elements to relieve symptoms • Interprofessional Communication: Review interprofessional communication best practices to provide optimal care for patients regarding oral and systemic health Don’t miss out on this opportunity to deepen your knowledge! #OralSystemicConnection #ContinuingEducation #AutoimmuneDisorders

Join us for the second webinar in The Oral-Systemic Connection Series! Date: September 6th Time: 11am-12pm ET Register Here: https://bit.ly/3WLIW3a This CME/CE-accredited session, titled "Oral Impact of Immunosuppression and Auto-Immune Disorders," will cover: • Oral Effects: Review oral effects of auto-immune disorders such as Sjogren’s Syndrome and cancers as well as side-effects from cancer treatments and other systemic therapies (BRONJ, etc) • Treatment Modalities: Discuss treatment modalities and options on both the oral and systemic elements to relieve symptoms • Interprofessional Communication: Review interprofessional communication best practices to provide optimal care for patients regarding oral and systemic health Don’t miss out on this opportunity to deepen your knowledge! #OralSystemicConnection #ContinuingEducation #AutoimmuneDisorders

A 61-year-old woman presented hemodynamic instability associated with myocarditis, colitis, hepatitis, hypothyroidism, polyradiculoneuropathy and these cutaneous lesions. The patient had been receiving treatment for clear cell renal cell carcinoma and had completed the third infusion of pembrolizumab. She was also prescribed axitinib. What is most likely diagnosis? 1) Disseminated petechia associated with sepsis 2) Thrombosing vasculopathy due to disseminated intravascular coagulopathy 3) Catastrophic antiphospholipid syndrome 4) Immune-related adverse event Write your answer in the comments, and find out more here 👉 https://hubs.li/Q02JlkvZ0

Today marks #WorldLeukemiaDay, a global call to action. By recognizing the signs and symptoms, we can change the story for leukemia patients everywhere. Your voice could be the difference that leads to early diagnosis and better care. #BeLeukemiaAware #WLD24 #leukemiaawareness

Hepatocellular carcinoma (HCC) can be a complex disease to manage. Here, Jun Gong, MD discusses the typical patient journey in advanced #HCC diagnosis, and the importance of educating patients and setting treatment goals with them.

What are the specific challenges faced by patients with rare Pulmonary cancers? Explore the unique challenges faced by individuals with rare pulmonary cancers, including delayed diagnosis, limited treatment options, and emotional toll. https://lnkd.in/gt5AFuYX #rarecancer #pulmonarycancer #cancerawareness #healthcare #patientadvocacy

How does communication play a role when symptoms, treatment and care take time to manifest? Our latest #LLYCIDEAS "Blood also gets sick" highlights the impact of blood cancers and uncovers advances in research and therapy development, but also highlights the lack of access to innovative treatments. It also highlights the role of communication in these processes to achieve early diagnosis and improve the quality of life of patients. Learn more 🔎https://ow.ly/jKEE30sAQQa

How does communication play a role when symptoms, treatment and care take time to manifest? Our latest #LLYCIDEAS "Blood also gets sick" highlights the impact of blood cancers and uncovers advances in research and therapy development, but also highlights the lack of access to innovative treatments. It also highlights the role of communication in these processes to achieve early diagnosis and improve the quality of life of patients. Learn more 🔎https://ow.ly/l4fZ30sAUl6

Dear all, We invite you to read white paper of Call to Action developed by the ECAMET Alliance on topic of Staff Shortages and Burn Out in Cancer Medication Administration in Europe https://lnkd.in/eSwBUnbU #ESNO #nursingshortage #nursingproblems #LetsActNow

You can read #ecamet white paper about ‘’Staff Shortages and Burn Out in Cancer Medication Administration in Europe’’ supported by ESNO, European Specialist Nurses Organisation https://lnkd.in/eSwBUnb #ESNO #nursingshortage #nursingproblems #LetsA